From: Xanthine oxidoreductase gene polymorphisms are associated with high risk of sepsis and organ failure
 | Total | Sepsis (w/o ARDS) | Sepsis (w/ ARDS) | ||||||
---|---|---|---|---|---|---|---|---|---|
European American | African American | P | European American | African American | P | European American | African American | P | |
N | 621 | 353 | Â | 324 | 195 | Â | 297 | 158 | Â |
Sex (M/F) | 352/269 | 176/177 | 0.05 | 175/149 | 89/106 | 0.07 | 177/120 | 87/71 | 0.37 |
Age (yrs) | 60.0 ± 16.7 | 54.8 ± 17.3 | < 0.0001 | 62.6 ± 15.8 | 58.9 ± 16.2 | 0.01 | 57.3 ± 17.2 | 49.7 ± 17.2 | < 0.0001 |
APACHE II | 25.7 ± 8.0 | 25.3 ± 8.1 | 0.38 | 23.9 ± 8.1 | 23.8 ± 7.4 | 0.87 | 27.8 ± 7.5 | 27.1 ± 8.6 | 0.42 |
Mortality (%) | 32.53 | 36.54 | 0.21 | 26.23 | 26.15 | 1.0 | 39.39 | 49.37 | 0.05 |
Insult (%) Lung Blood Abdomen UTI Other | 302 (49.6) 70 (11.5) 88 (14.4) 72 (11.8) 77 (12.6) | 150 (44) 60 (17.6) 38 (11.1) 39 (11.4) 54 (15.8) | 0.03 | 105 (33.1) 42 (13.2) 55 (17.4) 61 (19.2) 54 (17) | 62 (32.8) 36 (19) 23 (12.2) 29 (15.3) 39 (20.6) | 0.16 | 197 (67.5) 28 (9.6) 33 (11.3) 11 (3.8) 23 (7.9) | 88 (57.9) 24 (15.8) 15 (9.9) 10 (6.6) 15 (9.9) | 0.13 |
Comorbidities (%) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
HIV | 4.52 | 17.85 | < 0.0001 | 3.10 | 15.90 | < 0.0001 | 6.06 | 20.25 | < 0.0001 |
AIDS | 2.58 | 11.90 | < 0.0001 | 2.17 | 8.72 | < 0.0001 | 3.03 | 15.82 | < 0.0001 |
RF | 45.48 | 44.76 | 0.84 | 43.65 | 44.62 | 0.85 | 47.47 | 44.94 | 0.62 |
CLD | 12.90 | 4.82 | < 0.0001 | 10.22 | 4.10 | 0.01 | 15.82 | 5.70 | 0.002 |
Diabetes | 26.45 | 35.41 | 0.004 | 30.65 | 43.08 | 0.01 | 21.89 | 25.95 | 0.35 |
Alcoholism | 16.13 | 18.98 | 0.29 | 11.15 | 16.41 | 0.11 | 21.55 | 22.15 | 0.91 |
COPD | 21.29 | 10.76 | < 0.0001 | 21.67 | 10.77 | 0.002 | 20.88 | 10.76 | 0.006 |
Cancer | 19.68 | 12.75 | 0.01 | 23.22 | 10.77 | < 0.0001 | 15.82 | 15.19 | 0.89 |
CHF | 11.29 | 11.08 | 1.0 | 11.76 | 11.79 | 1.0 | 10.77 | 10.19 | 1.0 |
Anemia | 18.55 | 17.00 | 0.60 | 19.50 | 21.03 | 0.73 | 17.51 | 12.03 | 0.14 |